InvestorsHub Logo
Followers 63
Posts 7608
Boards Moderated 1
Alias Born 01/02/2003

Re: Pharmacydude post# 371373

Monday, 02/21/2022 7:36:09 PM

Monday, February 21, 2022 7:36:09 PM

Post# of 429367
From SA..."Vascepa will likely be approved in China by the end of 2021, based on several clinical studies confirming the efficacy and safety of this medicine."...

What's up with the delay?...Is price holding up the approval of Vascepa in China?...With over 100 million people in China able to profit from taking Vascepa...i.e. by having a reduction in CVD, Amarin can afford to negotiate a lower price for China.





Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News